Physician profile
Gregory Keith Moore
NPI 1417958760
$1,143.24
in general payments reported to CMS, 2019-2025
19 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $307 · 2020: $300 · 2021: $163 · 2022: $178 · 2023: $195.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $195.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $194.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Silk Road Medical, INC. | $174.89 | 2023 | Enroute Transcarotid Stent, Enroute Transcarotid Neuroprotection System |
| Boston Scientific Corporation | $131.42 | 2022 | |
| Amarin Pharma, INC. | $125.78 | 2019 | |
| Lilly USA, LLC | $117.66 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $102.30 | 2019-2021 | |
| Pfizer INC. | $102.04 | 2019-2023 | |
| Axonics, INC. | $80.15 | 2021 | |
| Foundation Fusion Solutions, LLC | $54.06 | 2022-2023 | |
| Merck Sharp & Dohme LLC | $41.54 | 2020-2021 | |
| Amgen INC. | $38.64 | 2019-2020 | |
| Allergan, INC. | $29.99 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $29.32 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $24.46 | 2019 | |
| Glaxosmithkline, LLC. | $19.64 | 2020 | |
| Shire North American Group INC | $16.01 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lundbeck LLC | $15.85 | 2020 | |
| Mylan Specialty L.P. | $15.20 | 2021 | |
| Genentech USA, INC. | $13.11 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $11.18 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Moore listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.